WASHINGTON (Reuters) - Poor treatment may be fueling the rise of an especially hard to treat form of tuberculosis called extensively drug resistant or XDR TB, doctors reported on Sunday.
WASHINGTON (Reuters) - Poor treatment may be fueling the rise of an especially hard to treat form of tuberculosis called extensively drug resistant or XDR TB, doctors reported on Sunday.